FATE THERAPEUTICS INC
FATE·31189P102·US·Common Stock·Healthcare - Biotechnology-Activist
FATE (FATE THERAPEUTICS INC) is held by 81 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($19.7M), VANGUARD PORTFOLIO MANAGEMENT LLC ($12.3M), VANGUARD CAPITAL MANAGEMENT LLC ($12M). Net institutional sentiment: Mixed.
81
Holders
(7 Elite)
$123.2M
Total Value
54% (94)
Consensus
51 buying - 43 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 27, 2026 · Insiders Aug 5, 2026 · Activists Jul 8, 2026 · Congress none
InsiderVBValamehr BahramSell $108KAug 4, 2026
InsiderTCTAHL CINDYExercise 122K shMay 6, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 100
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer